ETON
Eton Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$55.50
−2.75%Forward multiples
Based on analyst estimates
- P/E forward
- 37.31x
- P/E 2026E
- 52.06x
- P/E 2027E
- 26.96x
- P/E 2028E
- 18.13x
- P/S forward
- 8.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- 119.35x
- PEG TTM
- 0.55x
- Price / book
- 34.05x
- Price / sales
- 15.02x
- Price / cash flow
- 104.81x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 15.04x
- EV / EBITDA
- 85.57x
- EV / EBIT
- 97.40x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026